BioPlx

About:

BioPlx is an advanced microbiome company that prevents infectious disease through the management of the microbiome.

Website: http://bioplx.com

Description:

BioPlx is an advanced microbiome company that prevents infectious disease through the management of the microbiome. It employs targeted microbiological agents to create unique interventional formulations. The company developing non-antibiotic methods for the control of infectious disease, including multiple-drug resistance “super-bugs". BioPlx creates live bio-therapeutic products that are backed by clinical data showing exceptional magnitude and significance in both safety and efficacy based on solid science, a strong management team and a broad pool of the intellectual property. It is designed to use both in-house and proprietary contract development and consulting strategies across the wide range of components and methods incorporated within this product line.

Total Funding Amount:

$2.72M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boulder, Colorado, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)bioplx.com

Founders:

Ravi Starzl, Tim Starzl

Number of Employees:

11-50

Last Funding Date:

2020-02-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai